Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States

NCT02857764 · clinicaltrials.gov ↗

COMPLETED

Status

127690

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Sponsor

Janssen Research & Development, LLC